Covalently closed circular DNA of hepatitis B virus (HBV) is critical for viral persistence in vivo. We recently reported a technique involving recombinant covalently closed circular DNA (rcccDNA) of HBV by site-specific DNA recombination. Using hydrodynamic injection, rcccDNA induces a temporarily prolonged HBV antigenemia in immunocompetent mice, similar to acute resolving HBV infection. In this study, we simulated the pathophysiological impact of chronic hepatitis to reproduce rcccDNA persistence in mouse models. We showed that rcccDNA achieved long-lasting persistence in the presence of a compromised immune response or when transcriptional activity was repressed. To closely mimic chronic hepatitis, we used a replication-defective recombinant adenoviral vector to deliver rcccDNA to the liver, which led to prominent HBV persistence throughout the experiment duration (>62 weeks) in transgenic mice expressing Cre recombinase under the albumin promoter. A sustained necroinflammatory response and fibrosis were identified in mouse livers, with dysplastic lesions commonly seen during the late stage of viral persistence, analogous to the progressive pathology of clinical chronic hepatitis. Conclusion: rcccDNA was intrinsically stable in vivo, enabling long-term persistence in the context of chronic hepatitis, and viral persistence, in turn, may promote progression of chronic liver disease; our study also presented a surrogate model of HBV cccDNA persistence in mice that could advance our understanding of the pathogenesis of chronic hepatitis B. (HEPATOLOGY 2018;67:56-70).
H
epatitis B virus (HBV) is a prototypical member of the hepadnavirus family of DNA viruses that preferentially target hepatocytes. Chronic infection may persist for life and cause varying degrees of liver pathogenesis including fibrosis, cirrhosis, and/or hepatocellular carcinoma. However, the pathogenetic mechanisms responsible for HBVassociated chronic necroinflammatory liver diseases are poorly defined, mainly due to the lack of suitable and convenient laboratory models.
HBV has a narrow host range, limited to humans and chimpanzees. Most studies so far on HBV immunopathogenesis have been conducted using HBV transgenic (Tg) mice.
(1) Adoptive transfer of HBV-specific cytotoxic T lymphocytes could activate a functional immune response to abrogate HBV transgene expression, similar to that which Abbreviations: Ad, adenoviral; Alb, albumin; ALT, alanine aminotransferase; a-SMA, alpha-smooth muscle actin; B 2 M, b 2 -microglobulin; cccDNA, covalently closed circular DNA; CD, cluster of differentiation; ChIP, chromatin immunoprecipitation; CMV, cytomegalovirus; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HBcAg, hepatitis B core antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HBx, HBV x gene; H&E, hematoxylin and eosin; IFN, interferon; nt, nucleotide; PBS, phosphate-buffered saline; PFU, plaque-forming unit; prcccDNA, precursor plasmid rcccDNA; rcccDNA, recombinant cccDNA; shRNA, short hairpin RNA; Tg, transgenic; wt, wild type.
occurs during clinical acute hepatitis. (2) In addition, in HBV Tg mice with severe combined immunodeficiency, chronic hepatitis was induced after immunological reconstitution with syngeneic naive splenocytes. (3) This model, however, is rarely seen in the literature, probably because it is technically complicated. Many studies also attempted to establish infection models in non-Tg mice, with HBV delivered by a non-HBV viral vector (4) (5) (6) or directly through hydrodynamic injection of naked plasmid DNA encoding the HBV genome. (7, 8) Of note, transfer of the HBV genome with low doses of adenoviral (Ad) vectors is reported to lead to persistent infection and a functionally impaired T-cell response against HBV in immunocompetent mice. (5) Mice are not infected with HBV because they lack a receptor(s) for viral entry. Also, for unknown reasons, HBV covalently closed circular (ccc) DNA is not formed in mouse livers. (9, 10) cccDNA exists as an episomal minichromosome in the nucleus of hepatocytes and is regarded as a primary molecular mechanism for HBV persistence. Although the amount is low, cccDNA is thought to have a loss rate that correlates only with mitosis or death of infected hepatocytes. (11) In patients with chronic HBV infection, cccDNA is resistant to sustained liver inflammation and cannot be eradicated by longterm antiviral treatments. (12, 13) We recently reported a technique involving HBV recombinant (r) cccDNA using site-specific DNA recombination. (14) Using hydrodynamic injection, rcccDNA induces a prolonged (5-7 weeks average) HBV antigenemia in a mouse model compared to regular HBV-encoding plasmids. This effect may reflect the intrinsic stability of rcccDNA in vivo.
Chronic viral hepatitis reflects a functionally impaired immune response that cannot efficiently eliminate the virus, and its potential to cause sustained immunopathology. (15, 16) In this study, we found that in immunocompetent mice rcccDNA achieved longlasting persistence under mimicked chronic hepatitis effects. Competence of host antiviral immunity was mainly responsible for clearance of rcccDNA in vivo. Virologic determinants were crucial for rcccDNA stability. Ad delivery induced prominent long-term rcccDNA persistence in a mouse model. Of particular interest, viral persistence elicited chronic hepatitis with progressive pathology in mouse livers and thus represented a surrogate model of cccDNA-based chronic HBV infection.
Materials and Methods

DNA CONSTRUCTS
HBV-related plasmids were constructed under a genotype D background (subtype ayw; GenBank accession no. V01460.1). Precursor plasmid rcccDNA (prcccDNA) was constructed as described (14) with a slight modification: the loxP-chimeric intron was simplified to a 118-nucleotide (nt) sequence (5 0 -GTAA  GTATCAAGGTTACAAGACAGGTTTAAGGA  GACCAATAACTTCGTATAATGTATGCTAT  ACGAAGTTATGCACCTATTGGTCTTACT  GACATCCACTTTGCCTTTCTCTCCACAG-3 0 , loxP site underlined). For construction of prcccDNAb 2 -microglobulin-specific short hairpin (sh) RNA (shB 2 M), a U6 promoter with a downstream coding sequence for shB 2 M (5 0 -CCGGCCAGTTTCTAA TATGCTATACCTCGAGGTATAGCATATTA GAAACTGGTTTTTG-3 0 ) was subcloned into prcccDNA at a site ahead of loxP2 (Fig. 1A) . To generate HBV x gene (HBx)-null mutants, a C at nt 22, numbered from the ATG start of the HBx gene, was mutated to T (CAA!TAA) using overlapping PCR.
The plasmid pCMV-KRAB-Cre encodes a KRAB domain-fused Cre recombinase under control of a cytomegalovirus (CMV) promoter. Briefly, we subcloned the coding sequence of Cre into pCDNA3.1(1) by PCR using forward primer 5 0 -ACAAGATCTGAATT 
RECOMBINANT Ad VECTORS
Recombinant Ad vectors were generated as described. (17) We constructed pShuttle-rcccDNA by inserting a floxed sequence of a 3 0 intron (46 nt), a monomeric HBV genome, and a 5 0 intron (38 nt) into a pShuttle plasmid (K1650-1; Clontech, Palo Alto, CA) digested with MluI and KpnI. pShuttle-rcccDNA was digested with I-CeuI and PI-SceI for fragments inserted into Ad plasmid pAdHu5 deleted for E1 and E3 genes to generate pAd/rcccDNA. The plasmid was digested with PacI and 
MICE
Wild-type (wt) male mice (C57BL/6) aged 4-5 weeks were hydrodynamically injected with DNA plasmids as described. (14) Albumin (Alb)-Cre Tg mice (C57BL/6-Tg [Alb-cre] 21Mgn/J) expressing Cre recombinase under the albumin promoter were from Jackson Laboratory (Bar Harbor, ME). For Ad/ rcccDNA transduction, 1.5 3 10 9 plaque-forming units (PFU) of vector were intravenously administered to Alb-Cre Tg mice (male, aged 6-8 weeks). All animal studies were approved by the Animal Ethics 
CHROMATIN IMMUNOPRECIPITATION
For experiments on liver tissue, mice were sacrificed on day 3 after DNA hydrodynamic injection. Livers were perfused with cold phosphate-buffered saline (PBS) and quickly cut into pieces. Crosslinking was at room temperature for 15 minutes with 1.5% formaldehyde and quenched by glycine at 125 mM final concentration. Single cells were separated using 100-lm cell strainers. Chromatin immunoprecipitation (ChIP) assays were performed as described. (14) Antibodies used in ChIP assays are listed in Supporting  Table S1 .
QUANTIFICATION OF rcccDNA IN MOUSE LIVERS
Total DNA was extracted from 25 mg liver tissue using QIAamp DNA Mini Kits (51306; Qiagen, Hilden, Germany). Quantitative PCR used SYBR green reagents (DRR041A; Takara, Dalian, China), and rcccDNA was amplified using primers P1 (5 0 -CAA-GACAGGTTTAAGGAGAC-3 0 ) and P2 (5 0 -CTGCGGTATTGTGAGGATTC-3 0 ), with relative amounts calculated using the 2 -DDCt method (normalized to glyceraldehyde 3-phosphate dehydrogenase [GAPDH]). Supporting Table S2 lists primers for quantification of Ad vectors.
QUANTITATIVE RT-PCR
Reverse transcription was performed using ReverTra Ace quantitative PCR RT Master Mix with gDNA Remover (Toyobo; FSQ-301). SYBR green reagents were used for quantitative PCR. Relative gene expression was analyzed using the 2 -DDCt method and normalized to that of GAPDH mRNA. Primers are listed in Supporting Table S3 .
HISTOLOGICAL ASSAY AND IMMUNOFLUORESCENCE STAINING
Hematoxylin and eosin (H&E), Masson's trichrome, and sirius red staining of formalin-fixed, paraffin-embedded liver tissues was by Servicebio (Shanghai, China). For immunofluorescence staining, liver cryosections were fixed with 4% formalin and permeabilized with 0.25% (vol/vol) Triton X-100 in PBS. After blocking with 20% goat serum, cryosections were incubated with anti-hepatitis B surface antigen (HBsAg) conjugated with fluorescein isothiocyanate (ab21021; Abcam, Cambridge, MA) and antihepatitis B core antigen (HBcAg; B0586; Dako, Glostrup, Denmark) at a dilution of 1:100. Secondary Alexa 555-labeled antirabbit (Invitrogen, Carlsbad, CA) was used for anti-HBcAg staining. After washing, liver sections were mounted with antifade reagent containing 4 0 ,6-diamidino-2-phenylindole.
STATISTICS
Data are expressed as means 6 standard errors of the mean. Unpaired Student t tests were performed with GraphPad Prism software.
OTHER MATERIALS AND METHODS
HBsAg and hepatitis B e antigen were quantified using an architect platform (Abbott). DNA and RNA hybridization, lymphocyte preparation, and flowcytometric analysis were as described. (14) Results
rcccDNA ACHIEVES LONG-TERM PERSISTENCE IN THE PRESENCE OF A COMPROMISED IMMUNE RESPONSE
During chronic hepatitis, functional impairment of HBV-specific T-cell responses is a principal reason for host inability to eliminate persistent infection. (15, 16) We thus engineered an shB 2 M expression cassette into an rcccDNA system (Fig. 1A) . As B 2 M is essential for surface expression of major histocompatibility complex class I, we expected that knockdown of B 2 M would reduce major histocompatibility complex-I-restricted peptide presentation in hepatocytes that coexpressed rcccDNA. The efficiency of shB 2 M was assessed in BNL CL.2 cells. Endogenous B 2 M was decreased by 60% after transfection with shB 2 M-encoding plasmids (Fig. 1B) . In a mouse model, coinjection of prcccDNA-shB 2 M with pCMV-Cre compromised the virus-specific T-cell response in the liver, as suggested by decreased liver-infiltrating lymphocytes with poor production of interferon (IFN)-c upon peptide stimulation compared to mice receiving prcccDNAshLuc or pwtHBV1.2 ( Fig. 1C; Supporting Fig. S1 ). Coexpression of rcccDNA with shB 2 M resulted in HBV persistence for at least 18 weeks in the mouse model ( Fig. 1D and data not shown) . Similar results were obtained when rcccDNA was coexpressed with a second shRNA targeting B 2 M (data not shown). By contrast, mice that received pwtHBV1.2-shB 2 M at varying doses developed transient antigenemia of HBsAg within 2-3 weeks after injection (Fig. 1E) . Therefore, the competence of host immunity was critical for viral persistence. Unlike conventional HBVencoding plasmids, rcccDNA uniquely established long-term persistence in the presence of a compromised immune response.
SUPPRESSION OF rcccDNA TRANSCRIPTION FACILITATES VIRAL PERSISTENCE IN THE MOUSE MODEL
Virologic inhibition is a principal effect of the host immune response against HBV. (18) (19) (20) (21) (22) We postulated that during chronic hepatitis repressed viral expression and the condensed architecture of cccDNA minichromosome may contribute to viral persistence. This hypothesis was supported in the mouse model after coinjection of prcccDNA with a plasmid expressing KRAB-Cre (Fig. 2A) . KRAB is 90 amino acids and a transferable module with DNA binding-dependent transcriptional repression activity. (23, 24) The KRABCre fusion protein induced rcccDNA with an efficiency similar to wt Cre ( Fig. 2B; Supporting Fig. S2 ). Consistent with KRAB-mediated epigenetic repression ( Fig. 2C; Supporting Fig. S2) , expression of HBsAg from rcccDNA KRAB-Cre was substantially reduced, as determined in mouse sera on day 3 after hydrodynamic coinjection (Fig. 2D) . Viral expression underwent a rebound at week 1, followed by a significantly prolonged antigenemia for at least 10 weeks. Compared to rcccDNA wt Cre , a higher level of rcccDNA KRAB-Cre was detected by quantitative PCR in mouse livers late after injection (Fig. 2B) .
To achieve constant transcriptional repression, we created an rcccDNA mutant with an HBx deletion. HBx is crucial for modulating chromatin-mediated transcriptional repression of cccDNA. (25, 26) In mouse livers on day 3 postinjection, acetylation of histones H3 and H4 and trimethylation of histone 3 lysine 9 (H3K79) were diminished in the HBx-null mutant, correlating with repressed chromatin structure (Fig.  2E) . HBV antigenemia for at least 40 weeks after injection (Fig. 2F, left) was observed in mice receiving the HBx-null mutant. Although deletion of the HBx gene also repressed viral expression from an HBVencoding plasmid (pwtHBV1.2 X-null ), intriguingly, injection of the plasmid resulted in only transient HBV antigenemia in the mouse model (Fig. 2F, right) . These results suggested that rcccDNA was intrinsically stable and could model long-term viral persistence in a setting of transcription repression.
rcccDNA TRANSDUCES MOUSE LIVER EFFICIENTLY THROUGH RECOMBINANT Ad VECTOR
Ad vectors are predominantly sequestered by the liver after intravenous administration, (27) without eliciting a robust T-cell response. (5, 28, 29) To closely mimic chronic viral hepatitis, we exploited an E1-deleted and E3-deleted human Ad vector (serotype 5) to deliver rcccDNA to mouse livers. rcccDNA was generated through Cre/loxP-mediated DNA recombination from the linear Ad vector (Ad/rcccDNA) (Fig. 3A) , similar to the prcccDNA plasmid system. (14) In wt (non-Cre Tg) C57BL/6 mice, intravenous injection of Ad/rcccDNA at 1.5 3 10 9 PFU led to mild expression of HBcAg that was mainly located in the nucleus of hepatocytes. Neither rcccDNA nor viral replicative DNA intermediates were detected. By contrast, rcccDNA was substantially induced in livers of Alb-Cre Tg mice after Ad transduction (Fig. 3B) , enabling active viral transcription and replication (Fig. 3C,D) . HBcAg expression increased, with apparent translocation to the cytoplasm (Fig. 3E) . Abundant expression of HBsAg was detected in most hepatic parenchymal cells, indicating extensive rcccDNA formation in the liver. In addition, a high HBV DNA titer of about 2.0 3 10 6 IU/mL was quantified by quantitative PCR in mouse sera 1 week after transduction. Thus, the recombinant Ad vector was competent for in vivo delivery of rcccDNA with high efficiency, making it a valuable strategy for developing a mouse model of rcccDNA-based HBV infection.
Ad-DELIVERED rcccDNA INDUCES PROMINENT HBV PERSISTENCE IN Alb-Cre Tg MICE
In Alb-Cre Tg mice, intravenous administration of Ad/rcccDNA (1.5 3 10 9 PFU) resulted in a large number of liver-infiltrating lymphocytes (12.07 6 1.942 3 10 6 ) with significantly increased frequency of cluster of differentiation 8-positive (CD8 1 ) T cells, as detected at week 2 postinfection ( Fig. 4A; Supporting Fig. S3 ). ENV353-pentamer-specific T cells represented 7.0 6 1.8% of CD8 1 T cells in mouse livers. However, programmed cell death protein 1 was highly expressed on liver-infiltrating CD8 1 T cells, especially pentamer-positive cells (Fig.  4B) , indicating impaired T-cell function. Few IFN-cpositive CD8
1 T cells were detected by ex vivo stimulation with HBV-related peptides (Supporting Fig. S3 ).
In the presence of the functionally impaired T-cell response, Ad-delivered rcccDNA achieved long-term persistence in livers of Cre Tg mice. Levels of rcccDNA appeared to peak at week 4, probably reflecting a rate- limiting step for Cre-mediated DNA recombination in cells with multiplicities of infection. Decay of rcccDNA was slow but still detectable by quantitative PCR at week 62 after infection (Fig. 4C) . Concurrent with rcccDNA formation, Ad/rcccDNA vector in the livers of Cre Tg mice was 4-fold to 5-fold reduced at day 3 after Ad infection compared with wt mice (Fig. 4D) . Transduction of nonparenchymal hepatic cells, which lack Cre, might account for the unprocessed Ad/rcccDNA in Cre Tg mouse livers. High serum HBsAg was observed as early as days 3-7 after infection; this declined to its lowest value at week 2. HBsAg antigenemia rose afterward to a plateau above 100 IU/mL and persisted throughout the experiment (>60 weeks). Hepatitis B e antigen persisted concurrently in mouse sera, although it decreased to baseline level over the late period (Fig. 4E ). Immunohistochemical staining also demonstrated long-term expression of HBcAg and HBsAg in liver tissues (Fig.  5A,B) . Collectively, the Ad vector facilitated efficient liver delivery of rcccDNA for establishing prominent HBV persistence in immunocompetent mice.
Ad-DELIVERED rcccDNA INDUCES CHRONIC HEPATITIS IN THE MOUSE MODEL
The replication-defective, E1-deleted Ad vector has been safely used in a variety of clinical studies. (30, 31) Consistent with the literature, (4) intravenous administration of an empty Ad vector (1.5 310 9 PFU) resulted in lowlevel Ad persistence (marginally detected at week 10 postinfection; data not shown) in mouse livers, without significant hepatic injury, as suggested by serum alanine aminotransferase (ALT) activity (Fig. 6A ) and histological examination (Figs. 6B and 7A) .
In Ad/rcccDNA-transduced Alb-Cre Tg mice, serum ALT values modestly increased at week 1 (117.8 6 13.5 IU/mL); interestingly, mice maintained elevated ALT activity, with fluctuations, over the next 60 weeks of the experiment (Fig. 6A) . This result provided evidence for chronic hepatitis in the mouse model. Sustained inflammation was revealed by significantly increased infiltrating lymphocytes and inflammatory foci in liver tissue sections at indicated time points (Figs. 5 and 6B) . Hepatocellular apoptosis/regeneration, a hallmark of chronic necroinflammatory liver disease, was identified in and adjacent to the inflammatory area by morphological features or Ki67 staining (Fig. 6B) . Chronic hepatitis in the mouse model was also evidenced by up-regulated expression of tumor necrosis factor-a and interleukin-6 with varying degrees over the viral persistence (Fig. 6C) . Interestingly, a marked increase of IFN-c expression was observed in mouse livers only at week 1 after infection. Collectively, Ad-delivered rcccDNA rather than the Ad vector induced sustained necroinflammatory response in mouse livers.
PROGRESSIVE LIVER PATHOLOGY IS ASSOCIATED WITH rcccDNA PERSISTENCE IN THE MOUSE MODEL
In the presence of sustained liver injury, liver fibrosis was observed in Alb-Cre Tg mice as early as 10 weeks after Ad/rcccDNA infection. Progressive liver scarring in the portal areas was seen by sirius red or Masson's trichrome staining of connective tissue and by alphasmooth muscle actin (a-SMA) staining, indicating ; ii, H&E stain of focal lesion with marked lobular disorganization; arrows, small portal vein obliteration; iii, upper right area of (ii) with higher magnification (cellular enlargement and hyperchromasia are typically seen in dysplastic foci); iv, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling stain; v and vi, H&E stain (v) or anti-HBcAg stain (vi) of mouse 2 lesion. (E) i, H&E stain of a large hepatic nodule in Cre Tg mouse at week 54 after transduction of Ad/rcccDNA; ii, hypercellularity of nodular lesion with compressed adjacent liver tissue (dotted line, boundary); iii, premalignant alterations in focal areas, i.e., irregular nuclear outline (triangles), mitosis (arrows), and necrosis (asterisk); iv, prominent microsteatosis with eosinophilic Mallory bodies. Bars, 100 lm. *P < 0.05, **P < 0.01. Abbreviations: Col1a1, alpha-1 type 1 collagen; MMP2, matrix metalloproteinase 2; TIMP1, tissue inhibitor of metalloproteinases-1; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling. activated hepatic stellate cells ( Fig. 7A; Supporting  Fig. S4) . (32) Infection of wt mice with Ad/rcccDNA or with empty Ad vector did not result in liver fibrosis at week 20 after infection. Relative mRNA expression of a-SMA, alpha-1 type 1 collagen, matrix metalloproteinase 2, and tissue inhibitor of metalloproteinases-1 was coordinately up-regulated with fluctuations in Ad/ rcccDNA-infected Cre Tg livers (Fig. 7B) .
Liver fibrosis occurred in five of eight Cre Tg mice that were sacrificed at week 20 after transduction with Ad/rcccDNA (Fig. 7C) . In two mice, pale neoplasm nodules were observed on the liver surface. Microscopic views of the lesions revealed typical large-cell change (33) and disordered lobular structure with portal venous obliteration (Fig. 7D) . Neoplastic lesions were associated with lobular and portal inflammation, where HBcAgpositive hepatocytes were readily detected. Interestingly, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling-positive cell clustering was seen in a local focus that was morphologically intact by H&E stain. Characteristics of premalignancy (33) were observed in the mouse model with age (two of nine in mice at weeks . Figure 7E shows a 1.5 3 1-cm nodule from a Cre Tg mouse at 54 weeks postinfection. The lesion was demarcated by compression of adjacent liver parenchyma and exhibited disarrayed architecture with increased cellularity, prominent microsteatosis, and inflammatory infiltration. Hepatocellular pleomorphism and atypical mitosis were also observed. Taken together, Ad-delivered rcccDNA induced chronic hepatitis and fibrosis with progressive liver pathology in the mouse model.
Discussion
Host immunity is critical for clearance of cccDNA or virus-infected cells. Our recent study showed that in immunocompetent mice rcccDNA induces a temporary but prolonged HBV antigenemia similar to acute resolving HBV infection. (14) By contrast, rcccDNA persisted for more than 1 year in immune-deficient Rag2 -/-mice without causing immunopathogenesis (unpublished data). To simulate a compromised immune response during chronic hepatitis, we designed a B 2 M-specific shRNA sequence inserted in a precursor rcccDNA plasmid. This approach allowed HBV and interfering shRNA to be coexpressed in the same hepatocytes, reducing antigenic stimulation and T-cell response against HBV in immunocompetent mice. Interestingly, this type of operation in a regular HBV-encoding plasmid did not improve HBV persistence in the mouse model.
Further thought is needed to understand the difference between rcccDNA and regular HBV-encoding plasmids. Chen and colleagues reported that a minicircle DNA vector (with a non-HBV transgene) devoid of bacterial sequences exhibited persistent expression in mouse livers, whereas a plasmid vector was silenced in cis by linkage of the transgene expression cassette to a bacterial backbone. (34) In a prcccDNA system, rcccDNA is generated in combination with a plasmid backbone circle at a 1:1 ratio after Cre/loxP-mediated DNA recombination. Interestingly, we found that in mice hydrodynamically coinjected with prcccDNA/pCMV-Cre clearance of the backbone circles was faster than clearance of rcccDNA in the same hepatocytes (Supporting Fig. S5 ). Thus, the backbone circle appeared to be less resistant to host clearance mechanisms than rcccDNA. However, due to detection limit, neither rcccDNA nor the backbone circle was readily detectable in mouse livers by quantitative PCR 3-4 weeks after injection.
During chronic hepatitis, antiviral immunity is functionally inefficient at eliminating viral persistence but has the potential to inhibit viruses. (18) (19) (20) (21) (22) To simulate transcriptional repression, we took advantage of the site-specific DNA-binding capacity of Cre to recruit a KRAB repressive module to rcccDNA. This method resulted in early virologic inhibition and significantly prolonged viral persistence in a mouse model. This result suggested that, compared to rcccDNA wt Cre , rcccDNA KRAB-Cre either elicited a relatively compromised immune response or was more resistant to immune clearance. In this regard, the condensed architecture of rcccDNA minichromosomes (19, 20) is likely to have increased resistance to clearance by host mechanisms. Similar results were observed in mice receiving an HBx-null mutant of rcccDNA. We note that HBx relieves chromatin-mediated transcriptional repression of HBV cccDNA. (25) Deletion of HBx from the viral genome may closely mimic an inactive state of the viral infection. These studies suggest that, rather than viral clearance, chronic inflammation may promote HBV cccDNA persistence in vivo. Deletion of HBx from the regular HBV-encoding plasmid did not improve HBV persistence in the mouse model.
Only about 4% of hepatocytes in mouse livers could be transfected by DNA hydrodynamic injection. (35) This appears to be a major obstacle to launching chronic hepatitis and accumulating pathology in the mouse model. We thus used an Ad vector to deliver rcccDNA to achieve high-efficiency liver transduction. The Ad vector is widely used for gene delivery and was predominantly sequestered by the liver after intravenous administration. Because of their immunogenicity, Ad vectors are often used as vehicles for vaccination; however, this feature is critically influenced by viral dose and vaccination route. (5, 28, 29) Direct intravenous administration of Ad vectors might compromise the immune response. Of note, a compromised immune response, rather than profound immune tolerance, is essential for establishing sustained liver injury in the mouse model. In this respect, adeno-associated virus-mediated gene transfer may lead to persistent HBV replication in mice with limited immunopathology. (6, 36) Ad-delivered rcccDNA minicircles are physically separated from linear Ad vectors through Cre-mediated DNA recombination. This method of rcccDNA delivery has biosafety potential because the HBV genome is functionally disabled within the Ad vector unless the Cre recombinase is coexpressed. In the presence of a functionally compromised immune response, both Ad vector and Ad-delivered rcccDNA achieved long-term persistence in the mouse model. Our results did not exclude the possibility that an Ad vector may directly promote the persistence of rcccDNA or vice versa. We note that empty Ad (at 1.5 3 10 9 PFU) was only marginally detected by quantitative PCR of mouse livers by 10 weeks postinfection (data not shown), whereas Ad vector carrying rcccDNA was readily and persistently detected in Cre Tg mice (Fig. 4D) . Replicationdefective E1-deleted Ad vectors were safely used in clinical studies. Therefore, Ad vector is thought to be noncytotoxic and unlikely to be involved in rcccDNA-based HBV immunopathology. We injected mice with empty Ad vector (at 1.5 3 10 9 PFU), which did not lead to sustained liver injury.
Little evidence so far suggests that cccDNA itself is directly cytotoxic. Thus, cccDNA-based persistent viral production appears to be largely responsible for chronic liver pathology in virus-infected patients. Albeit functionally inefficient, viral antigen-induced immune response during chronic infection is considered to have the potential to cause immunopathology. Moreover, increasing evidence suggests that HBV antigens are directly cytopathic to infected hepatocytes in pathophysiological settings. (37, 38) In agreement, we found that Ad/rcccDNA transduction led to a sustained increase in serum ALT activity in non-Cre Tg mice, presumably indicating a potential immunopathologic effect of HBcAg (data not shown). Interestingly, transduction of an Ad vector expressing an HBsAg transgene did not cause significant liver injury during Ad persistence (data not shown).
Chronic infection of HBV may persist for decades, with sustained hepatocellular damage fundamentally responsible for liver pathologies including hepatitis, fibrosis/cirrhosis, and carcinoma. In our study, although Ad-delivered rcccDNA caused prominent HBV persistence over the experiment duration, pathological changes in the mouse model might be relatively modest. We expect that typical, severe liver pathogenesis is likely to be achieved in the mouse model with a prolonged disease course. Apparently, aging is a main limitation of the mouse model.
Taken together, our results showed that rcccDNA was intrinsically associated with long-term HBV persistence in vivo. By delivering rcccDNA through an Ad vector, we succeeded in developing a mouse model that closely resembles clinical chronic viral hepatitis with progressive liver pathology. The surrogate model may advance our understanding of HBV infection and afford opportunities to develop powerful strategies to cure HBV infection.
